Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kymera Therapeutics Inc
(NQ:
KYMR
)
48.49
-1.26 (-2.52%)
Streaming Delayed Price
Updated: 1:14 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Kymera Therapeutics Inc
< Previous
1
2
3
Next >
Kymera Therapeutics Presents Preclinical Data Demonstrating Activity of KT-253, a Selective Heterobifunctional MDM2 Degrader, in Acute Myeloid Leukemia at the American Society of Hematology Annual Meeting
December 11, 2022
From
Kymera Therapeutics, Inc.
Via
GlobeNewswire
Kymera Therapeutics Provides Webcast Information for December 14 Investor Event
December 01, 2022
Company to Share Clinical Data from KT-474 Phase I Patient Cohort and Oncology Pipeline
From
Kymera Therapeutics, Inc.
Via
GlobeNewswire
Kymera Therapeutics Announces Third Quarter 2022 Financial Results and Provides a Business Update
November 03, 2022
From
Kymera Therapeutics, Inc.
Via
GlobeNewswire
Kymera Therapeutics Appoints Biopharmaceutical Leader Victor Sandor, M.D.C.M., to Board of Directors
November 03, 2022
From
Kymera Therapeutics, Inc.
Via
GlobeNewswire
Kymera Therapeutics to Report Third Quarter 2022 Results on November 3
October 20, 2022
Company also presenting at upcoming investor conferences
From
Kymera Therapeutics, Inc.
Via
GlobeNewswire
Kymera Therapeutics to Hold Investor Webcast on December 14 to Share Clinical Data from KT-474 Phase I Patient Cohort and Oncology Pipeline
October 13, 2022
From
Kymera Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.